findmyKOL
Clinical trialNCT00010803CompletedPhase 3Interventional

Ginkgo Biloba Prevention Trial in Older Individuals

SponsorNational Center for Complementary and Integrative Health (NCCIH)Enrollment3,069Alzheimer's DiseaseDementia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will determine the effect of 240mg/day Ginkgo biloba in decreasing the incidence of dementia and specifically Alzheimer's disease (AD), slowing cognitive decline and functional disability, reducing incidence of cardiovascular disease, and decreasing total mortality.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Steven T. DeKosky, M.D.

    University of Pittsburgh, Department of Neurology

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, Davis

    Sacramento, California, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Wake Forest University School of Medicine

    Winston-Salem, North Carolina, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

  • University of Pittsburgh/university of Virginia

    Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Ginkgo biloba extractPlacebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2000
Primary completion
30 Apr 2008
Completion
31 Jul 2011
Last update posted
14 Mar 2013
Registered enrollment
3,069
Registry id
NCT00010803

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.